158 related articles for article (PubMed ID: 26028296)
1. Role of receptor for advanced glycation end products in the complication and progression of various types of cancers.
Malik P; Chaudhry N; Mittal R; Mukherjee TK
Biochim Biophys Acta; 2015 Sep; 1850(9):1898-904. PubMed ID: 26028296
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of receptor for advanced glycation end products attenuate 17α-ethinyl-estradiol dependent proliferation and survival of MCF-7 breast cancer cells.
Lata K; Mukherjee TK
Biochim Biophys Acta; 2014 Mar; 1840(3):1083-91. PubMed ID: 24252278
[TBL] [Abstract][Full Text] [Related]
3. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response.
Chavakis T; Bierhaus A; Nawroth PP
Microbes Infect; 2004 Nov; 6(13):1219-25. PubMed ID: 15488742
[TBL] [Abstract][Full Text] [Related]
4. RAGE in tissue homeostasis, repair and regeneration.
Sorci G; Riuzzi F; Giambanco I; Donato R
Biochim Biophys Acta; 2013 Jan; 1833(1):101-9. PubMed ID: 23103427
[TBL] [Abstract][Full Text] [Related]
5. Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis.
Rojas A; Figueroa H; Morales E
Carcinogenesis; 2010 Mar; 31(3):334-41. PubMed ID: 20028726
[TBL] [Abstract][Full Text] [Related]
6. [Receptor of advanced glycation endproducts RAGE/AGER: an integrative view for clinical applications].
Barbezier N; Tessier FJ; Chango A
Ann Biol Clin (Paris); 2014; 72(6):669-80. PubMed ID: 25486663
[TBL] [Abstract][Full Text] [Related]
7. Role of receptor for advanced glycation end products (RAGE) and its ligands in cancer risk.
Yamagishi S; Matsui T; Fukami K
Rejuvenation Res; 2015 Feb; 18(1):48-56. PubMed ID: 25472493
[TBL] [Abstract][Full Text] [Related]
8. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.
Opatrna S; Popperlova A; Kalousová M; Zima T
Ther Apher Dial; 2014 Jun; 18(3):309-16. PubMed ID: 24965297
[TBL] [Abstract][Full Text] [Related]
9. Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities.
Lalla E; Lamster IB; Stern DM; Schmidt AM
Ann Periodontol; 2001 Dec; 6(1):113-8. PubMed ID: 11887453
[TBL] [Abstract][Full Text] [Related]
10. [Receptors for advanced glycation end products and their physiological and clinical significance].
Pietkiewicz J; Seweryn E; Bartyś A; Gamian A
Postepy Hig Med Dosw (Online); 2008 Oct; 62():511-23. PubMed ID: 18936727
[TBL] [Abstract][Full Text] [Related]
11. Cellular signalling of the receptor for advanced glycation end products (RAGE).
Xie J; Méndez JD; Méndez-Valenzuela V; Aguilar-Hernández MM
Cell Signal; 2013 Nov; 25(11):2185-97. PubMed ID: 23838007
[TBL] [Abstract][Full Text] [Related]
12. The receptor of advanced glycation end products plays a central role in advanced oxidation protein products-induced podocyte apoptosis.
Zhou LL; Cao W; Xie C; Tian J; Zhou Z; Zhou Q; Zhu P; Li A; Liu Y; Miyata T; Hou FF; Nie J
Kidney Int; 2012 Oct; 82(7):759-70. PubMed ID: 22622498
[TBL] [Abstract][Full Text] [Related]
13. Role of receptor for advanced glycation end products (RAGE) in liver disease.
Yamagishi S; Matsui T
Eur J Med Res; 2015 Feb; 20(1):15. PubMed ID: 25888859
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.
Sharaf H; Matou-Nasri S; Wang Q; Rabhan Z; Al-Eidi H; Al Abdulrahman A; Ahmed N
Biochim Biophys Acta; 2015 Mar; 1852(3):429-41. PubMed ID: 25514746
[TBL] [Abstract][Full Text] [Related]
15. What is the role of the receptor for advanced glycation end products-ligand axis in liver injury?
Basta G; Navarra T; De Simone P; Del Turco S; Gastaldelli A; Filipponi F
Liver Transpl; 2011 Jun; 17(6):633-40. PubMed ID: 21438128
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products and their receptor contribute to ovarian ageing.
Stensen MH; Tanbo T; Storeng R; Fedorcsak P
Hum Reprod; 2014 Jan; 29(1):125-34. PubMed ID: 24256989
[TBL] [Abstract][Full Text] [Related]
17. Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases.
Mahajan N; Dhawan V
Int J Cardiol; 2013 Oct; 168(3):1788-94. PubMed ID: 23722052
[TBL] [Abstract][Full Text] [Related]
18. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
Kuniyasu H; Chihara Y; Kondo H
Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
[TBL] [Abstract][Full Text] [Related]
19. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways.
Fuentes MK; Nigavekar SS; Arumugam T; Logsdon CD; Schmidt AM; Park JC; Huang EH
Dis Colon Rectum; 2007 Aug; 50(8):1230-40. PubMed ID: 17587138
[TBL] [Abstract][Full Text] [Related]
20. Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice.
Pusterla T; Nèmeth J; Stein I; Wiechert L; Knigin D; Marhenke S; Longerich T; Kumar V; Arnold B; Vogel A; Bierhaus A; Pikarsky E; Hess J; Angel P
Hepatology; 2013 Jul; 58(1):363-73. PubMed ID: 23504974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
